By 2022, the company Iomed expects to have a turnover of $1.83 million (€1.6 million), which is equivalent to tripling last year's sales. This boom "is...
Despite its desire to expand markets, Adntro already markets its tests in sixty countries on five continents, although the company's priority markets will continue to be...
Almirall, founded in 1943 and headquartered in Barcelona, is listed on the Spanish Stock Exchange and is a member of the Ibex 35. The company currently...
A total of 36 deals were closed in 2021, a lower number compared to the previous year (41), but higher in terms of average amount per...
In the summer, Inuba closed a $1.6 million (€1.4 million) financing round that was used to create the marketing team. Previously, in February 2020, the month...
The Minister reminded that the Inveat Plan will involve an overall investment of more than $900.5 million (€795 million) throughout Spain, which will enable the renewal...
Looking ahead to 2022, ZeClínics is preparing an artificial intelligence (AI) platform that collects and interprets data to identify potential therapeutic targets. To implement this novelty,...
White Bridge Investments currently holds 70% of the shares of Biofarma Group, while the remaining 30% belongs to Germano Scarpa and Gabriella Tavasani. White Bridge had...
Peptomyc has focused its project on the development of a new generation of cell-penetrating peptides (CPP) targeting the Myc oncoprotein, with the aim of treating different...
Qmenta needs $10 million to further expand. For the time being, the company's main front will remain neurological diseases. Currently, one billion people worldwide suffer from...